Eftilagimod Alpha Novel Triplet Combination is Well Tolerated, Generates CRs in Soft Tissue Sarcoma
Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.
Stay updated with breaking news from Bone Sarcoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.
In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma.
Tests comparing artificial intelligence and standard biopsies revealed that AI had an 86% greater success rate than its competitor, suggests new researc...
A recent study conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) highlights AI's capabilities in assessing cancer aggressiveness.
Researchers have developed an algorithm that predicts how aggressive a tumour is likely to be more accurately than a biopsy.